Vimarsana
Biggest News Aggregation in the World

Page 2 - Invo Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Invo Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Invo Bioscience Today - Breaking & Trending Today

Breaking Stock News - INVO Bioscience (NASDAQ: INVO) and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company - Vimarsana News

Breaking Stock News - INVO Bioscience (NASDAQ: INVO) and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company

Breaking Stock News - INVO Bioscience (NASDAQ: INVO) and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company

INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET - Vimarsana News

INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...

INVO Bioscience, Inc. (NASDAQ:INVO) Q2 2023 Earnings Call Transcript - Vimarsana News

INVO Bioscience, Inc. (NASDAQ:INVO) Q2 2023 Earnings Call Transcript

Operator: Good afternoon. And welcome, to the INVO Bioscience Second Quarter Fiscal Year 2023 Financial Results Conference Call. All participants will be in listen-only mode.

INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 - Vimarsana News

INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with...

INVO Bioscience Announces Closing of $4.5 Million Public Offering - Vimarsana News

INVO Bioscience Announces Closing of $4.5 Million Public Offering

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...